Campaign for the launch of Imlygic™ (Talimogene Laherparepvec), an oncolytic viral therapy for certain melanoma cancers that was the first of its kind in the U.S. I designed and produced animated and still web banners, informational emails, print ads, and a patient and doctor-facing website for the treatment.

Above: Print ad concept.

Below: Web banners with immune response messaging.
Below: Web banners with trigger response messaging.
Below: Email campaign.
Back to Top